Disordered Purinergic Signaling Inhibits Pathological Angiogenesis in Cd39/Entpd1-Null Mice
Shaun W. Jackson(Center for Infectious Disease Research), Simon C. Robson(Beth Israel Deaconess Medical Center), Eva Cszimadia(Harvard University), Tomokazu Hoshi(Beth Israel Deaconess Medical Center), Xiaofeng Sun(Lanzhou Petrochemical Polytechnic), Christian Sundberg(Goethe University Frankfurt), Yan Wu(Nebraska Medical Center), Keiichi Enjyoji(Beth Israel Deaconess Hospital)
Cited by 98
Related Papers
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
|The Journal of Experimental Medicine|2007|2.4k
Negative feedback control of neuronal activity by microglia
|Nature|2020|997
The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance
|Purinergic Signalling|2006|928
The ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets
|Immunological Reviews|2017|901
Purinergic Signaling during Inflammation
|New England Journal of Medicine|2012|703